Ranking Value in Cancer Care: Analysis of a "Pathways" Approach

Michael Kolodziej, MD, and J. Russell Hoverman, MD, PhD
Published: Monday, Aug 13, 2012


Dr. Michael Kolodziej

Michael Kolodziej, MD

Dr. J. Russell Hoverman

J. Russell Hoverman, MD, PhD

Author Affiliations:

From New York Oncology Hematology and Albany Cancer Center (MK), Albany NY; Texas Oncology (JRH), Austin, TX; and US Oncology (MK, JRH), Houston, TX.

Amid a continuing debate over healthcare spending in the United States, the oncology community is growing more introspective about the costs associated with increasingly sophisticated cancer therapeutics.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Practice Connections™: From Diagnosis to Emerging Immunotherapeutic Options: Understanding the Burden and Risks in Peanut AllergySep 28, 20191.0
Enduring CME activity from the School of Breast Oncology®: 2018 Mid-Year Video UpdateSep 28, 20192.0
Publication Bottom Border
Border Publication